LTZ Therapeutics

About:

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Website: http://www.ltztherapeutics.com/

Top Investors: Qiming Venture Partners, Shunwei Capital, K2VC, GL Ventures LLC, K2 Venture Capital

Description:

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Total Funding Amount:

$47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2022-01-01

Founders:

Robert Li

Number of Employees:

11-50

Last Funding Date:

2024-07-30

IPO Status:

Private

Industries: